Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Naturex, Inc. engages in the manufacture, marketing and distribution of natural ingredients for the food, pharmaceutical and cosmetic industries. The company is headquartered in South Hackensack, NJ.

The Monsanto Company (/mɒnˈsæntoʊ/) was an American agrochemical and agricultural biotechnology corporation founded in 1901. In 2018, it was acquired by Bayer as part of its crop science division. It was headquartered in Creve Coeur, Missouri. Monsanto developed Roundup, a glyphosate-based herbicide, in the 1970s, and became a major producer of genetically engineered crops.

Bionovo, Inc. operates as a late stage clinical drug discovery and development company focusing on women’s health and cancer primarily in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its lead drug candidate is Menerba, a receptor sub-type selective estrogen receptor modulator, which is in Phase III clinical trial for the treatment of vasomotor symptoms of menopause. The company is also developing Bezielle, an oral anti-cancer agent that in Phase II clinical trail for the treatment of advanced breast cancer; and Seala for the treatment of post-menopausal vulvar and vaginal atrophy. Bionovo, Inc. was founded in 2002 and is headquartered in Emeryville, California. On October 26, 2012, Bionovo, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Northern District of California.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Dexa Medica has grown from a small company founded in 1969 to become one of the largest ethical pharmaceutical companies in Indonesia at the beginning of the 21st century. And now, it has become a respected leading company in the domestic pharmaceutical market. Providing better health services by applying expertise as the foundation set by the company's founder, namely; trust, dedication and commitment to providing the highest quality ethical and OTC products are maintained. Supported by a professional management team, and competent HR, Dexa Medica has developed a spirit of mutual respect, and innovation, for more than four decades. Dexa Medica products have also been marketed / exported to various countries in the Asia and Africa region. As a good company, one of our responsibilities to be a strategic asset in Indonesia is one of our expectations. Since long ago, Dexa Medica has collaborated with government agencies and the Indonesian Pharmaceutical Companies Association to comply with and improve industry standards.

Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany.

Bayer CropScience LP provides crop protection products. The company was founded on December 3, 1999 and is headquartered in Research Triangle Park, NC.

Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging. The Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers. The Healthcare Insights and Analytics segment provides indispensable insights to life sciences companies as well as healthcare providers and payers through a variety of high value-added data and analytics, research reports, and knowledge-based services. The company was founded on April 26, 1947 and is headquartered in Mumbai, India.

The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) is a multidisciplinary research institute located at Jakkur, Bangalore, India. It was established by the Department of Science and Technology of the Government of India, to mark the birth centenary of Pandit Jawaharlal Nehru, the first prime minister of independent India.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. They commitment and drive have propelled our growth from a single manufacturing facility during the genesis, to a range of world class manufacturing facilities spread across API, formulations and biotechnology. Headquartered in Pune, India, Emcure is today a vertically integrated pharmaceutical company with infrastructure, skills and resources that are at par with the best in the world. Our strengths span research to the manufacturing of APIs, Formulations and Biotechnology. The Company has carved a niche for itself as a preferred outsourcing partner for some of the largest MNCs both in India and global markets.

Prilenia Therapeutics Development Ltd., a subsidiary of Prilenia Therapeutics BV, is a company headquartered in Herzliya, Israel, that operates clinical stage biotech company. The firm was founded by Michael R. Hayden.\nThe company says this about itself: Prilenia is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders. Prilenia is based in Naarden, the Netherlands and Herzliya, Israel.

Apotex Pharmachem, Inc. operates as research and development manufacturing organization. It offers products in various categories, such as anti-bacterial, anti-diabetics, anti-viral, cancer, cardiovascular, CNS, gastrointestinal, ophthalmic, osteological, pain/inflammation, psychotherapeutic, respiratory and urological. The company was founded in 1974 and is headquartered in Brantford, Canada.